🇺🇸 FDA
Pipeline program

RO7197597

CO44195

Phase 2 small_molecule active

Quick answer

RO7197597 for Grade 1 Endometrial Cancer is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Grade 1 Endometrial Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials